A March 22 article by International Financial Law Review (IFLR) examines how under the U.S. Public Company Accounting Oversight Board’s (PCAOB) rules, hundreds of foreign public companies face delisting from trading on U.S. exchanges by the U.S. Securities and Exchange Commission (SEC) due to lack of compliance with auditing requirements. With more than 200 US-listed Chinese companies potentially impacted, in the piece titled “US-listed Chinese companies contemplate next steps,” life sciences partner Eric Wu in discusses this issue in relation to companies in the China life sciences space.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.